http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020186247-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36389cdf579846a37f770c664b61f7ca |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate | 2020-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f2cbaa2b067e1d9c8654b77e3910322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cdcb1429c3a9903dea3073776777ea0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8e95cb8594bdff257244421afae80c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7023244527da3c0f6095e9a496a6bf89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf8fa576b20f1d1218a5dd1dfd357f00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98d1b7a6a848fafb99ecf58f0f49967b |
| publicationDate | 2020-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2020186247-A1 |
| titleOfInvention | Compositions and methods for promoting islet viability and enhancing insulin secretion |
| abstract | Compositions and methods for regenerating pancreatic islet viability and/or cell proliferation in vitro, ex vivo, and/or in vivo; and/or for regenerating glucose-stimulated insulin secretion; and/or for regenerating viability and/or cell proliferation of a transplanted pancreatic islets; and/or for preventing and/or inhibiting rejection of a transplanted islets; and/or for pancreatic islet transplantation; and/or for treating a symptom of a condition, disorder, or disease associated with abnormal insulin responsiveness to glucose are provided. In some embodiments, the compositions include a peptide and/or a pharmaceutically acceptable salt thereof, and/or a biologically active fragment, analog, or derivative thereof, wherein the peptide, the pharmaceutically acceptable salt thereof, and/or the biologically active fragment, analog, or derivative thereof has an amino acid sequence of any of SEQ ID NOs: 1-60, or any combination thereof. |
| priorityDate | 2019-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 281.